Hugel Inc.
10Patents
10Active
10Granted
47Portfolio score
Filing activity: Aug 28, 2017 → Sep 23, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10772943B2 | Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor | Emerging Cross-Sectional Technologies | 6 | Active |
| US11147860B2 | Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor | Emerging Cross-Sectional Technologies | 1 | Active |
| US10866232B2 | Cell-based method for determining an activity of botulinum toxin | Physics | 0 | Active |
| US11360081B2 | Cell-based method for determining an activity of botulinum toxin | Physics | 0 | Active |
| US11224640B2 | Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US11169144B2 | Cell-based method for determining an activity of botulinum toxin | Physics | 0 | Active |
| US10823725B2 | Cell-based method for determining an activity of botulinum toxin | Physics | 0 | Active |
| US10525111B2 | Microstructure formulation techniques for botulinum toxin | Human Necessities | 0 | Active |
| US10792400B2 | Microstructure formulation techniques for botulinum toxin | Human Necessities | 0 | Active |
| US10908148B2 | Cell-based method for determining an activity of botulinum toxin | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.